NCT01210859撤回不适用
Effects of Antimuscarinic Drugs on OAB Symptoms After Insertion of Ureteral Stents
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
研究概览
简要总结
The purpose of this study is to check whether antimuscarinics that usually broadly used in the treatment of overactive bladder symptoms are effective in the treatment of those symptoms after insertion of ureteral stents. In order to study the efficacy of the treatment of OAB symptoms in stented patients the investigator will use a suitable questionnary.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •everyone who underwent ureteral stent insertion and started the treatment with detrusitol
排除标准
- •adverse affects of detrusitol or unwillness of the patient to continue the treatment with detrusitol, cronic renal or hepatic failure
研究者
相似试验
已完成
2 期
Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder SyndromeOveractive BladderNCT01167257Buddhist Tzu Chi General Hospital62
已完成
2 期
Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor OveractivityOveractive BladderNCT00648310Università degli Studi dell'Insubria
已完成
4 期
Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive BladderOveractive BladderNCT00836381Samsung Medical Center56
已完成
4 期
Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder SyndromeOveractive BladderNCT01824420Buddhist Tzu Chi General Hospital129
终止
不适用
Over Active Bladder Patients Having Sling SurgeryOveractive BladderNCT00852696Cleveland Clinic Florida1